Mr. Graham Orriss
Chief Executive Officer
SV Labs Corporation
480 Airport Boulevard
Watsonville , CA 95076
United StatesFEI 2130687Issued Dec 9, 2025Center for Veterinary Medicine
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 2130687.
Violations5
Issue DateDec 9, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
SV Labs Corporation
Location
Mr. Graham Orriss
Chief Executive Officer
SV Labs Corporation
480 Airport Boulevard
Watsonville , CA 95076
United States
FEI Number
2130687
Country
United States
Issue Date
December 09, 2025
Issuing Office
Center for Veterinary Medicine
Product Type
Drugs
Status
Open
Summary
SV Labs Corporation's Prescott, Wisconsin facility manufactured adulterated veterinary and over-the-counter human drug products due to significant Current Good Manufacturing Practice (CGMP) violations, specifically failing to thoroughly investigate out-of-specification test results before releasing products to customers. The company released an SPF 30 sunscreen lotion lot that failed microbial testing with a "too numerous to count" result without conducting proper root cause investigation, and this represented a repeat violation as the firm had previously been cited for the same non-compliance during an earlier FDA inspection. The violations violated 21 CFR 211.192 requirements for batch investigation and rendered the drug products adulterated under the Federal Food, Drug, and Cosmetic Act.
SV Labs Corporation FDA Warning Letter, December 9, 2025